---
title: 'F073 DTx series 2/5: What''s Pharma got to do with digital therapeutics? (Paul Simms)'
type: 'episode'
url: 'https://doc.social/episodes/f073-dtx-series-2-5-whats-pharma-got-to-do-with-digital-therapeutics-paul-simms'
show: 'Faces of Digital Health'
show_url: 'https://doc.social/podcasts/faces-of-digital-health'
published: '2020-04-04'
audio: 'https://traffic.megaphone.fm/DHT9243842676.mp3'
---

# F073 DTx series 2/5: What's Pharma got to do with digital therapeutics? (Paul Simms)

Paul is the CEO and Founder of Eyeforpharma - international hub connecting senior-level pharma executives, patient groups and other health stakeholders to exchange ideas and observe shifting trends and practices at events, in reports and conferences. In...

## Summary

Paul is the CEO and Founder of Eyeforpharma - international hub connecting senior-level pharma executives, patient groups and other health stakeholders to exchange ideas and observe shifting trends and practices at events, in reports and conferences. In this second episode of a short series about digital therapeutics, Paul talks about the relationship between Pharma and DTx and Pharma development as an industry in general. As an Advisor to Hu-manity.co Paul also discussed the concept of people owning their data and managing it as property.

Webinar about innovation financing in times of COVID-19: https://www.eventbrite.com/e/healthcare-innovation-financing-in-times-of-covid-19-tickets-101653044994
Recap of the show: www.facesofdigitalhealth.com/blog/f073-dtx-series-24-whats-pharma-got-to-do-with-digital-therapeutics-paul-simms